Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Clinician Exhaustion Is the Biggest Barrier to AI Adoption
Clinician exhaustion has emerged as the primary obstacle to widespread AI adoption in healthcare, according to Dr. Jesse Ehrenfeld, Aidoc’s global CMO. While AI promises efficiency, many clinicians view new tools as additional burdens that exacerbate burnout. Vendors are therefore pressured to demonstrate tangible workflow improvements rather than just technical performance. The industry’s focus is shifting from pure accuracy metrics to real‑world impact on daily clinical tasks.
He Survived a Misdiagnosis. Then He Built an AI Platform for Clinical Decisions.
Clement Okoh survived a misdiagnosed multiple myeloma and founded Monte Sereno Health in 2021, an AI‑powered healthcare operating system aimed at unifying Africa’s fragmented medical landscape. The platform embeds an AI agent, StarPilot, that offers real‑time decision support, pulls patient...
Normal Bloodwork ≠ Healthy: Most Adults Have Hidden Metabolic Risk
Lie I was taught in medical school: if a patient's standard bloodwork is normal, they're healthy. Reality: only about 7% of American adults are metabolically healthy. The other 93% pass routine labs while quietly drifting toward heart attacks, strokes, dementia, and...
Why Protocol Complexity Keeps Increasing – and How to Fix It
Protocol complexity in late‑stage trials is spiraling, with Phase III studies now averaging about 6 million data points—a rise of roughly 11% each year. The growth is fueled by scientific advances, global regulatory demands, and the ease of capturing extra data via...
Independent Medical Practice Runs on Operations
Independent physicians are finding that clinical training leaves them unprepared for the operational hurdles that determine a practice’s survival. Credentialing delays of 90‑180 days can stall cash flow while rent, payroll and software costs continue. Without specialty‑specific benchmarks, practices struggle...
AI Empathy Exposes Gaps; Tech Should Free Clinicians
AI’s perceived empathy highlights systemic gaps in health care, suggesting technology should restore, not replace, the human connection in medicine by freeing clinicians from administrative burdens. healthcareinnovation
Surgeons Discuss Toric IOL Planning, Focusing on Incisions
In the latest CEDARS/ASPENS debate, leading ophthalmologists examined toric IOL planning with a focus on incision management. They highlighted how modern femtosecond lasers enable 2.4 mm temporal incisions that produce negligible surgically induced astigmatism (SIA), typically under 0.25 D. The discussion emphasized...
Viz.ai and NRHA Collaborate to Deploy AI in Rural Hospitals
Viz.ai has teamed up with the National Rural Health Association to launch a Rural Hospital & Clinic Partnership Program aimed at narrowing the AI adoption gap in U.S. rural hospitals. Rural facilities are 25% less likely to adopt new technologies...
Pa. City Approves $2.8M 5-Year Ambulance Contract Following Hospital Closure
Chester, Pennsylvania approved a five‑year, $2.8 million contract with nonprofit VMSC Emergency Medical Services to provide ambulance coverage after the bankruptcy‑induced closure of Crozer Heath Hospital. In its first year, VMSC handled 8,324 calls, cut average response times from over 12...
New GLP‑5 Study Is Only Mouse
A friendly reminder, just because that new Nature study on a quintuple agonist (LOL GET READY FOR "GLP-5" discourse) is out today: It's a study on MICE. MICE TESTING IS NOT HUMAN TESTING. IT'S JUST MICE.
Doctor Wait Times Rising: Hidden Healthcare Inventory Exposed
In 2007, it took 18 days to see a doctor. Today it's 31. "There is hidden inventory in healthcare." - @oliver_kharraz on why the doctor shortage isn't the whole story. WATCH / LISTEN: Spotify: https://t.co/u05FAZy03v Apple: https://t.co/RZx2r8ixFD Youtube: https://t.co/fr1PiqjSZl
The FDA Real Time Clinical Trial Announcement Quietly Dissolves Phase Gates, Breaks Biotech Capital Markets Plumbing, and Opens a Founder...
The FDA announced on April 28 that real‑time clinical trials (RTCTs) are now live, with AstraZeneca’s phase‑2 lymphoma study and Amgen’s phase‑1b small‑cell lung cancer trial streaming data through Paradigm Health. The agency claims a 20‑40 % reduction in development timelines, but...
Qubit Pharma Teams Up with Singapore’s Quantum Hub
A fantastic partnership between @qubit_pharma and the Centre for Quantum Technologies in Singapore (@quantumlah)! Excited to be part of this journey and looking forward to the breakthroughs ahead.
Teleflex Hires Jason Weidman as CEO
Teleflex announced that Jason Weidman, a two‑decade Medtronic veteran who most recently led its coronary and renal denervation business, will become president and CEO on June 8. The appointment comes as Teleflex moves to divest its acute‑care, interventional urology and OEM...
Consumer Health Data’s Regulatory Patchwork Is Growing. Relief Isn’t Coming.
The U.S. health‑data privacy regime is fracturing as HIPAA enforcement wanes and states race to fill the gap with their own laws. Consumer‑facing apps, wearables and AI tools are collecting sensitive information that falls outside traditional covered‑entity rules, creating a...
Aster DM Healthcare Q4 Revenue Jumps 18% YoY to Rs 1,182 Crore
Aster DM Healthcare reported Q4 revenue of Rs 1,182 crore (≈$142 million), an 18% year‑on‑year increase, while operating EBITDA rose 31% to Rs 253 crore (≈$30.5 million) and margins expanded to 21.7%. On a pro‑forma basis that includes Quality Care India Ltd, revenue reached Rs 2,361 crore (≈$285 million)...
Year Two Funding Crisis: Grants Dry, Competition Rises
With federal research funding cuts, the first year of Trump 2.0 was tough. Year 2 is in some ways grimmer, a @statnews survey shows. Bridge funding is drying up, existing grants are ending & competition for fewer new grants is...
Repurpose, Don’t Replace: Three Ways Digital Agents Are Improving Phone Access
Healthcare providers are grappling with long hold times and high call abandonment, with 60% of patients hanging up after a minute. AI‑enabled digital agents are being deployed to handle routine administrative calls, freeing staff for complex, empathetic interactions. Early adopters...
Healthcare AI Governance: Implementing NIST Trustworthy AI and OWASP Security Guardrails
The article outlines how healthcare providers can operationalize AI governance by adopting NIST’s Trustworthy AI characteristics and OWASP’s security guardrails. It advises treating AI risk like any enterprise risk, appointing accountable executives, and building a cross‑functional oversight committee. A balanced...
Hospice Scammer Receives 2-Year Prison Sentence
Alex Alexsanian, 48, received a 27‑month federal prison term for orchestrating a $14 million Medicare fraud scheme involving bogus hospice and diagnostic imaging services. He also pleaded guilty to conspiracy to commit money laundering and was ordered to forfeit $3 million. The...
Will AI Help You Live 50 More Years? Immunologist Derya Unutmaz Weighs In
In this episode, NIH‑funded immunologist Derya Unutmaz discusses his bold predictions that AI will usher in a "biosingularity"—a convergence of artificial intelligence and biotechnology that could extend human lifespan by decades and automate half of white‑collar work within the next...
Fragmented Care Transitions Leave Patients Unprotected
The care transitions conversations resonated most deeply. We still discharge patients into a fragmented system and hope for the best. #aging #health https://t.co/d8ZGVHqoMo
Better Prediction of Type 1 Diabetes Boosts Prevention Prospects
A jump in our ability to predict Type 1 autoimmune diabetes should help future preventive strategies @NatureGenet https://t.co/ako2Ic46QW https://t.co/XbW26qu5LE
Musculoskeletal Disorders Are Draining Employer Health Budgets — The Workplace Itself May Be the Cause
Musculoskeletal (MSK) disorders now represent one of the largest cost drivers for employers, affecting roughly half of workers with company‑provided health plans. Up to $90 billion in avoidable expenses stem from surgeries—many of which are unnecessary—and recurring pain after treatment. The...
Akeso’s ASCO Plenary Raises Questions on Lung Cancer Data
This week's Biotech Scorecard: An #ASCO26 mystery: What does Akeso’s primo plenary spot say about its ivonescimab lung cancer survival data? $SMMT If the news was good, we'd have heard by now, right? Or, is Akeso just being ultra conservative?...
Wearable Sweat Patch Detects Six Vitamins in Real Time, Hits 0.33 nM Sensitivity
Researchers have unveiled a flexible skin patch that measures six essential vitamins in sweat, achieving detection limits as low as 0.33 nanomolar for folic acid. Published in Nature Communications, the study demonstrates real‑time, non‑invasive micronutrient monitoring that could reshape personalized nutrition.
Ayush Conclave Pushes Meditation and Yoga Into Mainstream Indian Healthcare
The Ayush Conclave in New Delhi brought together Union Minister Prataprao Jadhav, senior AYUSH officials, and industry CEOs to map how meditation, yoga and other traditional practices can be woven into contemporary healthcare. Participants stressed evidence, quality control and regulatory...
Clinical Trial Finds Rapamycin Undermines Exercise Gains in Older Adults
Researchers led by Brad Stanfield reported that a 13‑week, randomized trial of 40 sedentary older adults in New Zealand found rapamycin blunted the physical benefits of a modest home‑exercise program. Participants taking the drug showed weaker strength, more fatigue and...
Pregnancy Complications Linked to Stress, Heart Risk
Researchers analyzing the nuMoM2b‑HHS cohort found that women who experienced adverse pregnancy outcomes and sustained moderate‑to‑high psychosocial stress showed higher diastolic blood pressure up to seven years after delivery. The study followed more than 3,300 first‑time mothers, identifying three stress‑trajectory...
IBS News Flash. Late Night Eating + Stress = Bowel Dysfunction
A study presented at Digestive Disease Week found that eating late at night while experiencing high stress nearly doubles the odds of constipation or diarrhea, affecting roughly 40% of participants with both habits. The same combination was linked to reduced...
STAT+: Pharmalittle: We’re Reading About a Supreme Court Hearing on ‘Skinny Labels,’ AstraZeneca U.K. Expansion, and More
AstraZeneca announced a $400 million investment to complete the Rosalind Franklin building in Cambridge and launch a new digital‑focused laboratory in Macclesfield, reviving UK R&D expansion after the US‑UK trade deal lifted NHS cost‑effectiveness thresholds. Meanwhile, the U.S. Supreme Court heard...
FDA Grants Priority Review to BeOne’s TEVIMBRA Combo for HER2+ Gastric Cancer
The U.S. Food and Drug Administration has granted priority review to BeOne Medicines’ TEVIMBRA (tislelizumab) combined with ZIIHERA (zanidatamab) and chemotherapy for first‑line treatment of HER2‑positive gastroesophageal adenocarcinoma. The decision follows a Phase 3 trial that showed a median overall survival...
Chiesi to Acquire KalVista for $1.9 B, Adding First Oral HAE Therapy
Chiesi Group announced a $1.9 billion cash deal to buy KalVista Pharmaceuticals, paying $27 per share—a 36% premium—to acquire the FDA‑approved oral hereditary angioedema therapy Ekterly. The transaction, slated to close in the third quarter of 2024, marks Chiesi’s largest acquisition...
Pfizer Unveils Nanoparticle Platform Aimed at Precision Cancer Therapy
Pfizer disclosed a nanotechnology‑based drug‑delivery platform that uses engineered nanoparticles to target tumors with high precision. The initiative, led by Puja Sapra of the Targeted Therapeutics Unit, seeks to reduce collateral damage to healthy cells and could reshape oncology pipelines.
GLP-1 Microdosing May Provide More ‘Tailored Approach to Care’
At the 2026 AACE conference, clinical pharmacist Anne M. Komé highlighted off‑label microdosing of GLP‑1 receptor agonists as a strategy to improve tolerability and lower costs for patients. She explained that fractional dosing of drugs such as Saxenda, Victoza, Ozempic...
GSK's EXDENSUR Secures FDA Approval with Groundbreaking Twice‑Yearly Dosing for Severe Asthma
GlaxoSmithKline's depemokimab, branded EXDENSUR, received FDA approval on Dec. 16, 2025 as an add‑on therapy for severe eosinophilic asthma. The biologic is administered subcutaneously at 100 mg once every six months, a dosing interval not seen before in this therapeutic class. Approval was...
Avalyn Pharma Prices $300 Million IPO at $18 per Share, Expanding Biotech B2B Financing
Avalyn Pharma announced the pricing of its upsized initial public offering, selling 16.67 million shares at $18 each to raise $300 million. The Nasdaq‑listed biotech will use the proceeds to advance its pulmonary‑fibrosis pipeline and deepen B2B collaborations across the pharmaceutical supply...
Roon AI-Native Physician Network Launches to Replace MedTwitter with High-Trust Knowledge Exchange
Roon, an AI‑native digital community founded by former Pinterest executive Vikram Bhaskaran and neurosurgeon Dr. Rohan Ramakrishna, has launched a dedicated platform for verified physicians to exchange clinical expertise. The network, positioned as a high‑trust replacement for the waning “MedTwitter,”...
Mother and Baby Mental Health Unit to Go Ahead
The Northern Ireland health minister announced that a permanent mother‑and‑baby mental‑health unit will be built on the Belfast City Hospital site, with a design team appointed immediately. The unit, slated to open no later than the 2028/29 fiscal year, will...
Cuba Is Running Out of Time. We Need Fuel Now to Save Lives | Francisco Pichón
Cuba is facing a deepening energy crisis that has already forced hospitals to postpone tens of thousands of surgeries and disrupted prenatal, dialysis and cancer care. The shortage of fuel hampers water pumping, food services, ambulance operations and the movement...
Phoenix IVBM Spotlights Oncology Innovation, Access Barriers, and Partnerships
The Institute for Value‑Based Medicine gathered oncology leaders in Phoenix on March 19, 2026 to examine how cutting‑edge therapies move from academic centers to community practices. Panels showed that private‑practice ownership can speed drug adoption, while payer denials and pathology...
WellSky and AutoMynd Launch First Ambient AI Documentation for Personal Care Agencies
WellSky, in partnership with AutoMynd, is launching WellSky Ambient Documentation for Personal Care, an AI‑driven tool embedded in its EHR platform. The solution records spoken client intake data in real time, automatically populating ADL, IADL and preference fields. Early adopters...
Cigna To Exit Obamacare In 2027, Affecting Coverage For 369,000
Cigna announced it will exit the individual Affordable Care Act (Obamacare) market by the end of 2027, affecting roughly 369,000 members across 11 states. The move was disclosed alongside a first‑quarter net income of $1.7 billion, while enrollment in its ACA...
HTN Now: Sharing Best Practices From Success in Health Tech for NHS Trusts
Health tech leaders from the NHS and Restore Information Management gathered to discuss best practices in digital transformation. They highlighted successes such as moving 500,000 patient records to digital platforms, deploying ambient voice technology that added 1,200 notes in a...
Qp:Qs = 2.29. Now What?
The post highlights that calculating a Qp:Qs ratio of 2.29 is straightforward, but interpreting it correctly is where most sonographers stumble. Without the broader clinical picture, the ratio can misguide diagnosis and treatment planning. The author promises a step‑by‑step guide...
BeOne Receives the US FDA Priority Review to Tevimbra Combination for 1L Treatment of HER2+ GEA Cancers
The U.S. FDA granted priority review to BeOne Medicines’ Tevimbra‑Ziihera‑chemotherapy regimen for first‑line treatment of unresectable HER2‑positive gastric, gastro‑esophageal junction and esophageal adenocarcinomas. The decision follows the Phase III HERIZON‑GEA‑01 trial, which enrolled 914 patients and compared the new combos against...
Canada First in G7 to Approve Generic Ozempic
Health Canada has granted approval for the first generic version of semaglutide, the active ingredient in Ozempic, making Canada the first G7 nation to do so. The generic injection, submitted by Dr. Reddy’s Laboratories, is indicated for once‑weekly treatment of adult...
Federal Zero Trust Advisory Skips Healthcare — But Reads as a Hospital Medical Device Cybersecurity Roadmap
Federal agencies released a 28‑page zero‑trust advisory for operational technology that omits any reference to hospitals, patients, or medical devices. The guidance outlines four OT constraints—availability, legacy infrastructure, minimal logging, and cross‑functional workflows—that map directly onto the challenges of managing...
Specialty Drugs Now Consume over Half of Total Drug Spend
Specialty drugs now represent more than half of total prescription spending, despite treating a relatively small patient pool. A 2024 Pharmaceutical Strategies Group survey shows 43% of employers and health‑plan leaders cite managing specialty drug costs as their top priority,...
RAAS Inhibitors Show Benefits in Pediatric CKD Vs. CCBs
A new comparative‑effectiveness study of 2,762 children with chronic kidney disease (CKD) found that renin‑angiotensin‑aldosterone system (RAAS) inhibitors significantly outperformed calcium‑channel blockers (CCBs) in preventing progression to dialysis or transplant. Over a two‑year follow‑up, RAAS users had a 42% lower...